TB

This brochure for patients describes the new 12-dose treatment for latent TB infection (LTBI).

This issue focuses on the story of Raquel Orduño, whose on-going TB advocacy began with a group of people who came together to document and portray their experiences with TB along the United States (U.S.)-Mexico border. It also includes information on advocacy, social support and supportive language.

This report summarizes the accomplishments and activities of the Stop TB Partnership in 2011.

Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers. This guide is designed to be used in combination with the WHO TB Prevalence Surveys: A Handbook.

This document lists the essential research questions that will provide a common framework for various scientific disciplines to work concurrently and collaboratively towards better TB control and elimination.

Dr. Kenneth Castro explains why it is important for people living with HIV to be tested for TB.

This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.

This course was designed to give hands-on practice in identifying when and how an Isoniazid Preventive Therapy (IPT) program can be used in the prevention of tuberculosis in people living with HIV. Depending on individual pace and previous knowledge, this course requires around 30 to 45 minutes to complete.

This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.